Wenying Yu

State Key Laboratory Of Natural Medicines, No. 639 Longmian Dadao
Nanjing, 211198, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

Identification and Biological Evaluation of Juglone-Derived STAT3 Inhibitors against Colorectal Cancer.

Identification and Biological Evaluation of Juglone-Derived STAT3 Inhibitors against Colorectal Cancer.

Journal: ACS medicinal chemistry letters

Published: March 20, 2026

DB-2B, a Novel and Selective STAT3 Inhibitor Inhibits Colorectal Cancer Progression In Vitro and In Vivo.

DB-2B, a Novel and Selective STAT3 Inhibitor Inhibits Colorectal Cancer Progression In Vitro and In Vivo.

Journal: Biomolecules

Published: December 17, 2025

Discovery of Juglone Derivatives as Novel STAT3 Inhibitors with Potent Suppression of Cancer Cell Stemness against Breast Cancer.

Discovery of Juglone Derivatives as Novel STAT3 Inhibitors with Potent Suppression of Cancer Cell Stemness against Breast Cancer.

Journal: Journal of medicinal chemistry

Published: July 10, 2025

Modular Synthesis of Arylpyridylmethylamines via Visible-Light-Driven Reductive Coupling of Amines, Aldehydes, and Pyridines.

Modular Synthesis of Arylpyridylmethylamines via Visible-Light-Driven Reductive Coupling of Amines, Aldehydes, and Pyridines.

Journal: Chemistry (Weinheim an der Bergstrasse, Germany)

Published: February 17, 2025

In situ self-assembled cell reservoir hydrogel for maneuvering multistage radioimmunotherapy.

In situ self-assembled cell reservoir hydrogel for maneuvering multistage radioimmunotherapy.

Journal: Nature communications

Published: January 10, 2025

Discovery of novel pyridine skeleton derivatives as potent CLK2/3 inhibitors.

Discovery of novel pyridine skeleton derivatives as potent CLK2/3 inhibitors.

Journal: Bioorganic & medicinal chemistry letters

Published: October 17, 2024

Biodegradable persistent ROS-generating nanosonosensitizers for enhanced synergistic cancer therapy by inducing cascaded oxidative stress.

Biodegradable persistent ROS-generating nanosonosensitizers for enhanced synergistic cancer therapy by inducing cascaded oxidative stress.

Journal: Nanoscale horizons

Published: September 19, 2024

New Strategies for Responding to SARS-CoV-2: The Present and Future of Dual-Target Drugs.

New Strategies for Responding to SARS-CoV-2: The Present and Future of Dual-Target Drugs.

Journal: Journal of medicinal chemistry

Published: July 05, 2024

In Silico Prediction of Human Organ Toxicity via Artificial Intelligence Methods.

In Silico Prediction of Human Organ Toxicity via Artificial Intelligence Methods.

Journal: Chemical research in toxicology

Published: June 10, 2023

Near-Infrared-Activatable PROTAC Nanocages for Controllable Target Protein Degradation and On-Demand Antitumor Therapy.

Near-Infrared-Activatable PROTAC Nanocages for Controllable Target Protein Degradation and On-Demand Antitumor Therapy.

Journal: Journal of medicinal chemistry

Published: June 06, 2023

Targeting serine- and arginine-rich splicing factors to rectify aberrant alternative splicing.

Targeting serine- and arginine-rich splicing factors to rectify aberrant alternative splicing.

Journal: Drug discovery today

Published: March 31, 2023

Towards understandings of serine/arginine-rich splicing factors.

Towards understandings of serine/arginine-rich splicing factors.

Journal: Acta pharmaceutica Sinica. B

Published: January 13, 2023

Showing 1-12 of 43

Last Updated: 09/26/2026